載入...
Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis
Rationale. Rheumatoid arthritis (RA) and systemic juvenile arthritis (sJA) are the most frequent rheumatic diseases in adults and adolescents, consequently. Biologics disease modifying antirheumatic drugs (bDMARDs) are eff ective in treatment of RA and s JA. Aim. To perform health-economic analysis...
Na minha lista:
Main Authors: | , , , , |
---|---|
格式: | Artigo |
語言: | Russo |
出版: |
Izdatelstvo OKI
2020-05-01
|
叢編: | Качественная клиническая практика |
主題: | |
在線閱讀: | https://www.clinvest.ru/jour/article/view/486 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|